PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Sep-2023 DUPIXENT® (DUPILUMAB) SBLA FOR TREATMENT OF EOSINOPHILIC ESOPHAGITIS (EOE) IN CHILDREN AGED 1 TO 11 ACCEPTED FOR FDA PRIORITY REVIEW Regeneron
27-Sep-2023 palleos healthcare Advances Clinical Trial Execution with Veeva Vault Clinical Data Applications Veeva Systems
27-Sep-2023 Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services Cellectricon
27-Sep-2023 MedShr’s Digital Medical Education for Doctors Wins Hat-Trick of Awards MedShr
27-Sep-2023 GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development ProBioGen and GeoVax Labs, Inc.
27-Sep-2023 Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy Evotec SE
27-Sep-2023 Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa Cosmo Pharmaceuticals N.V.
26-Sep-2023 AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer’s conference AlzeCure
26-Sep-2023 UCB announces approval of RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in Japan UCB
26-Sep-2023 Northern Gritstone and Argobio Studio back Sheffield University spin-out Crucible Therapeutics Crucible Therapeutics
26-Sep-2023 Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review Regeneron Pharmaceuticals
26-Sep-2023 In vitro lung cell exposure systems by VITROCELL at EUROTOX 2023 VITROCELL
26-Sep-2023 Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation Acesion Pharma
26-Sep-2023 Polpharma Biologics Announces Approval of Europe’s First and Only Biosimilar for Multiple Sclerosis - Tyruko® (Natalizumab) Polpharma Biologics
26-Sep-2023 Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals Biosynth
26-Sep-2023 Lundbeckfonden BioCapital and +ND Capital join forces: New investment in novel hormone-free fertility treatment for women Lundbeckfonden BioCapital
26-Sep-2023 MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications MC2 Therapeutics
26-Sep-2023 GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development B3C newswire
26-Sep-2023 Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases Evotec SE
26-Sep-2023 Polpharma Biologics Announces Approval of Europe’s First and Only Biosimilar for Multiple Sclerosis - Tyruko® (Natalizumab) B3C newswire